Home · Articles · Best compounding pharmacy for tirzepatide

Best compounding pharmacy for tirzepatide (2026): 14 pharmacies checked against FDA records

Released: October 16, 2026 · Last reviewed: October 16, 2026 · Researched by Dr. Parmis (medical researcher) · Medically reviewed by Dr. Jonathan Snipes, MD and Kim Callender, NP (FNP-BC)

People search for “OptioRx reviews”, “Drug Crafters tirzepatide”, “ProRx reviews” and dozens of other pharmacy names because the pharmacy, not the telehealth brand, is the company that actually makes compounded tirzepatide. We checked 14 pharmacies that patients ask about against FDA’s 503B registry, warning letters, inspection records (Form 483s) and recalls, and against court records, as of October 16, 2026.

The short answer

No compounding pharmacy is FDA-approved, and there is no official “best” one. What you can compare is the record. Among the 14 we checked, Absolute Pharmacy and MediVera had no FDA warning letters, Form 483s or recalls that we could find from 2023 to October 2026. ProRx and Empower had the most actions: six each. Red Rock, Hallandale and Strive each had one Form 483.

The provider matters as much as the pharmacy: a program that names its pharmacy lets you look up this record before you pay. NexLife, our #1-ranked provider, names three on its plan pages: Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux’s New Drug Store (Lake Charles, LA).

14 tirzepatide pharmacies: what the records show

“Programs that name it” comes from the program’s own pharmacy page unless marked third party or reported. Accreditation claims (PCAB, LegitScript) are each pharmacy’s own and were not checked against the registries.

503A or 503B: why it matters for tirzepatide

A 503A pharmacy compounds for an individual prescription under state board oversight. A 503B outsourcing facility makes batches under federal manufacturing rules and is inspected by FDA. 503B sounds safer, but for tirzepatide it carries a specific problem: FDA’s April 7, 2026 warning letter to ProRx says tirzepatide “does not appear on the 503B bulks list,” so tirzepatide compounded from bulk substance by a 503B does not qualify for the 503B exemptions. FDA proposed on April 30, 2026 to keep semaglutide, tirzepatide and liraglutide off that list. See our 503B bulks-list explainer.

Additives: B12, glycine and niacinamide

Several pharmacies add a vitamin or amino acid to tirzepatide: Strive lists glycine and B12, Empower lists niacinamide, and partner pages list niacinamide for OptioRx and B12 or glycine for Drug Crafters. In a March 12, 2026 open letter, Eli Lilly said its testing found “significant levels of an impurity” formed when tirzepatide reacts with B12, and asked FDA to recall such products. That is Lilly’s claim; we found no FDA statement on it as of October 16, 2026. FDA’s own GLP-1 page reports more than 730 adverse-event reports for compounded tirzepatide as of May 31, 2026, without establishing cause. More in our additives guide.

Names that are not what they seem

• BioStrategix is not a pharmacy as far as we could confirm. It sells products labelled “For laboratory research use only. Not for human or veterinary consumption.”
• “Nova” can mean White Label Pharmacy dba Nova Pharmacy (a Katy, TX 503B registered December 2025), Nova Specialty Pharmacy (Texas), or NOVARX, a New York GLP-1 seller that is not a pharmacy and received FDA warning letter 728290 on June 8, 2026.
• “Apothecary” most likely refers to Apothecary Pharma (Cary, NC), the one two telehealth programs name for tirzepatide, but The Apothecary Pharmacy in Stafford, TX also sells compounded tirzepatide.

How to check any pharmacy in five minutes

1. Ask your provider which pharmacy fills your prescription. If they will not say, treat that as an answer.
2. Search the pharmacy on FDA’s registered outsourcing facilities list (503B) and FDA’s warning-letter search.
3. Look up its license on your state board of pharmacy’s website.
4. Check the label for additives and the beyond-use date, and ask for a certificate of analysis.
5. Avoid anything sold “for research use only”: it is not a legal prescription drug.

Records read October 16, 2026. FDA lists, inspection pages and court dockets change; check the live sources below before deciding. Nothing here is medical advice.

Frequently asked questions

What is the best compounding pharmacy for tirzepatide?

There is no FDA-approved or official best one. Among the 14 pharmacies we checked on October 16, 2026, Absolute Pharmacy and MediVera had no FDA warning letters, Form 483s or recalls that we found from 2023 to October 2026, while ProRx and Empower had six actions each.

Is ProRx a good pharmacy for tirzepatide?

ProRx is an FDA-registered 503B facility in Exton, PA, but it received FDA warning letters on December 20, 2024 and April 7, 2026 and recalled products in August 2024 and October 2025. The 2026 letter says tirzepatide is not on the 503B bulks list.

Is OptioRx legit?

OptioRx lists four pharmacies (Braun PharmaCare, Enovex, SBH Medical and Oakdell Compounding) on its site, and we found no FDA warning letters, Form 483s or recalls for 2023–2026. Telehealth partners say it supplies tirzepatide with niacinamide. A trade outlet reported a Chapter 11 filing in June 2024.

Which pharmacy does NexLife use?

NexLife’s plan pages name Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux’s New Drug Store (Lake Charles, LA).

Is a 503B pharmacy safer than a 503A for tirzepatide?

Not automatically. 503B facilities follow federal manufacturing rules, but FDA says tirzepatide is not on the 503B bulks list, so 503B tirzepatide made from bulk substance does not qualify for 503B exemptions. Check the specific pharmacy’s FDA record either way.

Informational only, not medical advice. Compounded drugs are not FDA-approved and are not the same products as Mounjaro® or Zepbound® (trademarks of Eli Lilly and Company). Prices and policies were read on the companies' own pages on the date shown and can change.